Divergent surgical outcomes for CACNA1D- and KCNJ5-mutant aldosteronomas are traceable to their cell-of-origin and most differentially expressed gene, CCM2L
Only 30% of patients with unilateral primary aldosteronism were cured by adrenalectomy, with significant differences in gene expression linked to mutation types.
Where it sits
this study against the rest of the snap-8 corpusSummary and findings
This study investigates the differential surgical outcomes for aldosterone-producing adenomas (APAs) with KCNJ5 and CACNA1D mutations. The analysis included gene expression profiles from 28 samples, with a focus on the gene CCM2L, which was found to be 33-fold upregulated (p=10^-26). The findings suggest that the cellular origin of these mutations may influence clinical outcomes.
Abstract
<title>Abstract</title> <p>In a recent prospective trial in which adrenalectomy cured only 30% of 78 patients with apparently unilateral primary aldosteronism, somatic KCNJ5 and CACNA1D mutations of the aldosterone-producing adenoma (APA) had opposite influences on rates of biochemical and clinical success. We sought explanations in the bulk and single-cell gene expression profiles of the resected APAs. The most significantly differentially expressed transcripts were CCM2L (33-fold upregulated, p=10-26), a gene linked to endothelial-cell fate with highest physiological expression in splenic sinusoidal endothelial cells; and included seven neuro-medullary genes. To trace their lineage into CACNA1D-mutant APA, we analysed 10x single-nucleus RNA-seq of 140,742 cells from 28 samples, including 3 each of a CACNA1D- and KCNJ5-mutant APA and adjacent adrenal, and a separate pair of high-definition spatial transcriptomes. CYP11B2+ve nuclei of CACNA1D-mutant but not KCNJ5-mutant APAs, and of aldosterone-producing micronodules (APM) in adjacent adrenals, were enriched for CCM2L and the neuro-medullary genes. APMs frequently harbour CACNA1D mutations and are likely the precursor of CACNA1D-mutant APAs. Hybrid cortico-endothelial and cortico-medullary cells were identified on single-nucleus and high-resolution spatial analyses, and confirmed on confocal immunofluorescence. Pseudotime trajectories and snATAC-seq analysis of adrenal and spleen placed adrenal medulla upstream of APMs, and identified chromatin accessibility in CACNA1D-mutant APA nuclei common to both splenic and adrenal endothelial nuclei. Different cells of origin for CACNA1D-mutant and KCNJ5-mutant APAs can explain the multiplicity of CACNA1D mutations in APMs and consequently poorer outcomes associated with CACNA1D-mutant APAs.</p>